Seheult, J.N.; Otteson, G.E.; Weybright, M.J.; Timm, M.M.; Han, W.; Jevremovic, D.; Horna, P.; Olteanu, H.; Shi, M.
Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry. Cancers 2025, 17, 1688.
https://doi.org/10.3390/cancers17101688
AMA Style
Seheult JN, Otteson GE, Weybright MJ, Timm MM, Han W, Jevremovic D, Horna P, Olteanu H, Shi M.
Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry. Cancers. 2025; 17(10):1688.
https://doi.org/10.3390/cancers17101688
Chicago/Turabian Style
Seheult, Jansen N., Gregory E. Otteson, Matthew J. Weybright, Michael M. Timm, Wenchao Han, Dragan Jevremovic, Pedro Horna, Horatiu Olteanu, and Min Shi.
2025. "Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry" Cancers 17, no. 10: 1688.
https://doi.org/10.3390/cancers17101688
APA Style
Seheult, J. N., Otteson, G. E., Weybright, M. J., Timm, M. M., Han, W., Jevremovic, D., Horna, P., Olteanu, H., & Shi, M.
(2025). Clinical Validation and Post-Implementation Performance Monitoring of a Neural Network-Assisted Approach for Detecting Chronic Lymphocytic Leukemia Minimal Residual Disease by Flow Cytometry. Cancers, 17(10), 1688.
https://doi.org/10.3390/cancers17101688
